Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 115 clinical trials
Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis

endostatin (commercially available in China)which is also administrated via the hepatic artery. The hypothesis of this protocol is that TACE with antiangiogenic treatment may inhibit the

local therapy
chemoembolization
transcatheter arterial chemoembolisation
angiogenesis inhibitor
TACE
  • 2 views
  • 07 Nov, 2020
  • 1 location
Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma

advanced and no curative therapies can be offered. At this stage, palliative therapy forms the mainstay of treatment. This includes TACE or Oral chemotherapy. Whether oral chemotherapy

cirrhosis
unresectable hepatocellular carcinoma
chemoembolization
cancer
TACE
  • 30 views
  • 07 Nov, 2020
  • 1 location
TACE Combined With PD-1 Knockout Engineered T Cell in Advanced Hepatocellular Carcinoma.

This study will evaluate the safety and effect of transcatheter arterial chemoembolization (TACE)combined with percutaneous transhepatic PD-1 knockout engineered T cell infusion in the Paitents

  • 0 views
  • 24 Jan, 2021
  • 1 location
TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC

This trial is is an open label, multicenter, randomized controlled phase 3 clinical trial. The purpose is to compare the efficacy and safety of lenvatinib plus TACE with lenvatinib alone for

  • 0 views
  • 23 Jan, 2021
  • 1 location
TACE Plus TKI and I-125 Seeds Brachytherapy for HCC With Branch PVTT

This study is conducted to evaluate the efficacy and safety of transarterial chemoembolization (TACE) combined with sorafenib/lenvatinib and iodion-125 seeds brachytherapy (TACE-TKI-I) compared

  • 0 views
  • 25 Jul, 2021
  • 1 location
DEB-TACE vs. cTACE as Conversion Therapy for Unresectable Large HCC

This study is conducted to evaluate the efficacy of drug-eluting bead transarterial chemoembolization (DEB-TACE) compared with conventional transarterial chemoembolization (cTACE) as the

  • 0 views
  • 25 Jul, 2021
  • 1 location
Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma

This study is the single-center, open-label phase I clinical trial to evaluate tolerability, safety and efficacy of Donafenib and JS001 in combination with TCAE in patients with Unresectable Hepatocellular Carcinoma.

  • 0 views
  • 02 Apr, 2021
  • 1 location
Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma

Chemoembolization (TACE) is used in the majority of advanced hepatocellular carcinomas. Randomized clinical trials indicated that TACE improves overall survival in patients with good

antineoplastic
cirrhosis
chemoembolization
angiogenesis inhibitor
TACE
  • 1 views
  • 07 Nov, 2020
  • 1 location
A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

Primary: To compare the efficacy of TACE and TAIE. Secondary: To compare the side effects of TACE and TAIE. The outcome measurements include survival benefit and tumour regression

interferon
cancer
chemoembolization
transcatheter arterial chemoembolisation
liver cancer
  • 1 views
  • 07 Nov, 2020
  • 1 location
The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma

To investigate the safety and efficacy of deferoxamine (DFO) combined with conventional transarterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma (HCC

  • 0 views
  • 22 Jan, 2021